Hospital Vall D'hebron
Clinical trials sponsored by Hospital Vall D'hebron, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Liver transplant study aims to unlock genetic secrets of colorectal cancer spread Results expected Dec 2026 (estimated)
- New hope for bile duct cancer: liver transplant after Chemo-Radiation Results expected Jun 2027 (estimated)
-
Can a mesh shield ovarian cancer patients from painful hernias?
Disease control Recruiting nowThis trial tests whether placing a surgical mesh during abdominal closure can prevent incisional hernias in women undergoing ovarian cancer surgery. It also examines if a negative pressure wound dressing reduces infection risk. Participants are randomly assigned to one of four gr…
Sponsor: Hospital Vall d'Hebron • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New hope for bile duct cancer: liver transplant after Chemo-Radiation
Disease control Recruiting nowThis study tests a new approach for people with a certain type of bile duct cancer that cannot be removed by surgery. Participants first receive chemotherapy and radiation, then a liver transplant. The goal is to see if this combination helps patients live longer and stay cancer-…
Sponsor: Hospital Vall d'Hebron • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Liver transplant study aims to unlock genetic secrets of colorectal cancer spread
Knowledge-focused Recruiting nowThis study looks at genetic changes in patients with colorectal cancer that has spread only to the liver and cannot be removed by surgery. Researchers will perform liver transplants and then analyze tumor genetics and blood samples to better understand why the cancer spreads and …
Sponsor: Hospital Vall d'Hebron • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC